Numoto S, Yoshida M, Otsuka H
Gan. 1981 Oct;72(5):647-54.
The carcinogenicities of N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) and N-ethyl-N-(4-hydroxybutyl) nitrosamine (EHBN) on the urinary bladder were compared in male BALB/c mice. The effect of cyclophosphamide (CPA) on the carcinogenicities was also investigated. The carcinogenic activity on the bladder mucosa of EHBN was similar to that of BBN, and there was no difference in the growth patterns, histological types or invasive characters of carcinomas induced by BBN and EHBN. Benign or malignant tumors of vascular origin developed in the urinary bladders of 15 mice treated with these carcinogens. The incidence of vascular tumors induced by EHBN was significantly higher than that of tumors induced by BBN. Intraperitoneal injections of CPA seemed to have no effect in the incidence of bladder carcinomas induced by these carcinogens, or on the development of vascular tumors in the bladder wall induced by EHBN.
在雄性BALB/c小鼠中比较了N-丁基-N-(4-羟基丁基)亚硝胺(BBN)和N-乙基-N-(4-羟基丁基)亚硝胺(EHBN)对膀胱的致癌性。还研究了环磷酰胺(CPA)对致癌性的影响。EHBN对膀胱黏膜的致癌活性与BBN相似,并且由BBN和EHBN诱导的癌在生长模式、组织学类型或侵袭特征方面没有差异。在用这些致癌物处理的15只小鼠的膀胱中出现了血管源性的良性或恶性肿瘤。EHBN诱导的血管肿瘤发生率显著高于BBN诱导的肿瘤。腹腔注射CPA似乎对这些致癌物诱导的膀胱癌发生率或EHBN诱导的膀胱壁血管肿瘤的发生没有影响。